Table 1 Characteristics of 76 study participants
Characteristic | Value |
|---|---|
Age, years | 52 ± 14 |
BMI, kg/m2 | 26.8 ± 5.2 |
Diabetes | 26% |
Smoking, never/former/current | 83% / 12% / 5% |
Type of allograft, alive | 74% |
Time since transplantation, years | 9.4 (IQR 4.0–16.0) |
eGFR (CKD-EPI), ml/min/1.73m2 | 62.2 (IQR 40.7–75.6) |
Creatinine clearance, ml/min | 61.7 (IQR 42.6–89.0) |
Urine protein excretion, mg/d | 210 (IQR 140–518) |
Hemoglobin, g/dl | 13.1 (IQR 11.8–14.3) |
Anti-hypertensive medications (any) | 74% |
 ACEi or ARBs | 50% |
 Beta blockers | 42% |
 Calcium channel blockers | 39% |
 Diuretics | 17% |
 Alpha blockers | 11% |
 Other anti-hypertensives | 1% |
 No. of antihypertensive medications | 1 (IQR 0–2) |
Aspirin | 26% |
Statins | 42% |